Euroclinic S.p.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Euroclinic S.p.A. - overview
Established
2003
Location
Ravenna, -, Italy
Primary Industry
Medical Devices & Equipment
About
Euroclinic S. p. A. is a medical equipment manufacturer specializing in outpatient solutions for ENT, podiatry, and gynecology.
Their focus is on customizable medical products that cater to healthcare providers worldwide. Founded in 2003 in Ravenna, Italy, Euroclinic S. p. A.
operates in the medical equipment sector, providing tailored solutions for outpatient facilities. The company has undergone strategic pivots to enhance its product offerings, retaining its position within the industry. Euroclinic S. p.
A. has successfully completed 2 deals, showcasing its growth trajectory. The firm's founder has a history of involvement in the medical devices industry, although further details are unavailable. Medi-Care Solutions s.
r. l, through its EUROCLINIC® brand, offers an extensive range of medical products designed for outpatient facilities in ENT, podiatry, and gynecology. Their offerings include specialized examination chairs, treatment units, diagnostic devices, and modular furniture. The company allows customization of products to meet specific practitioner needs and serves a diverse clientele across over 30 countries, ensuring compliance with international standards like CE, ISO, and FDA certifications.
In the most recent year, 2023, Euroclinic S. p. A. reported a revenue of USD 6,203,005.
20 with an EBITDA of USD 341,378. 60. The revenue is generated primarily through B2B transactions with healthcare facilities, leveraging partnerships with over 35 global distributors for product distribution. Looking ahead, Euroclinic S.
p. A. intends to expand its product line with new innovations aimed for release in the coming years. The company is targeting additional markets in Europe and Asia by 2025 to broaden its global footprint.
Recent funding will support these initiatives, focusing on the development of advanced medical equipment and enhancing market accessibility following Antares Private Equity's exit from the company.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.euroclinic.it
Total Amount Raised
Subscriber access only
Euroclinic S.p.A. - timeline of key events
Euroclinic S.p.A. - financials
| Fiscal Year Ended | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 2,225,552 | 4,251,256 | 3,830,990 | 3,853,025 | 4,264,723 | 4,434,610 | 3,956,050 | 4,102,534 | - | - | - |
| % Revenue Growth (YoY) | - | 91.0% | (9.9%) | 0.6% | 10.7% | 4.0% | (10.8%) | 3.7% | - | - | - |
| EBITDA (USD) | 226,593 | 160,526 | 139,240 | 185,632 | 150,362 | 181,100 | 131,766 | 264,158 | - | - | - |
| Operating Income (USD) | 217,421 | 102,238 | 74,783 | 111,319 | 61,441 | 93,386 | 80,139 | 86,799 | - | - | - |
| Operating Margin | 9.8% | 2.4% | 2.0% | 2.9% | 1.4% | 2.1% | 2.0% | 2.1% | - | - | - |
| % EBITDA Margin | 10.2% | 3.8% | 3.6% | 4.8% | 3.5% | 4.1% | 3.3% | 6.4% | - | - | - |
| NET Income (USD) | 135,630 | 49,399 | 27,887 | 54,110 | 19,145 | 40,239 | 23,195 | 21,518 | - | - | - |
| % Net Margin | 6.1% | 1.2% | 0.7% | 1.4% | 0.4% | 0.9% | 0.6% | 0.5% | - | - | - |
Euroclinic S.p.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Euroclinic S.p.A. | - | ||||||||
| Unspecified Exit | Completed | Euroclinic S.p.A. | - |
Displaying 1 - 2 of 2
Euroclinic S.p.A. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.